Table 1 Overview of the distinctive characteristics for each cluster (A-H)

From: The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact

 

Number of patients (n; % of cohort)

Tumor mutational burden (CDS)

SNV/InDel ratio

Number of structural variants

Main structural variant category or differentiating category

Ploidy status

Main mutational signature

Top 3 cluster-specific aberrations (% of cluster)

ETS-fusions (n)

Chromothripsis (n)

Kataegis (n)

Cluster A

13 (6.6)

36,88

0,99

149

None

1,92

MSI

MSH6 (69.2), JAK1 (69.2), CIC (58.3)

3

1

6

Cluster B

13 (6.6)

2,44

7,07

669

Tandem duplications (>100 kb)

2,39

N/A

CDK12 (84.6), FGF3 (69.2), FGF4 (69.2)

2

0

1

Cluster C

15 (7.6)

3,00

6,73

237

Tandem duplications (<100 kb)

3,19

N/A

None

7

1

2

Cluster D

22 (11.2)

4,39

7,28

323

Deletions (>100 kb)

2,16

BRCA

BRCA2 (68.2)

7

5

5

Cluster E

55 (27.9)

2,12

7,13

178

None

3,24

N/A

None

25

8

13

Cluster F

20 (10.2)

2,51

6,15

400

None

3,35

N/A

Chromothripsis (80,0)

10

16

7

Cluster G

34 (17.3)

2,12

6,13

222

None

2,98

N/A

None

23

8

5

Cluster H

25 (12.7)

2,30

5,81

201

Insertions

1,97

N/A

None

16

7

3

  1. All numbers are median of the cluster, unless otherwise indicated
  2. CDS coding sequence